Joint Research with the Osaka International Cancer Institute on Nucleic Acid Pharmaceuticals for Intractable and Rare Cancers
An individual project to establish a joint research department within the Osaka International Cancer Institute's research center and conduct drug discovery research on nucleic acid pharmaceuticals for intractable and rare cancers.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.